Home
Therapeutic Categories
- BACK
- Therapeutic Categories
- Allergy & Immunology
  - BACK
  - Allergy & Immunology
  - Chronic Spontaneous Urticaria
  - Food Allergies
  - Pediatric Food Allergies
  - Search for:
- Dermatology
  - BACK
  - Dermatology
  - Atopic Dermatitis
  - Plaque Psoriasis
  - Search for:
- Endocrinology
  - BACK
  - Endocrinology
  - Type 2 Diabetes
  - Search for:
- Gastroenterology
  - BACK
  - Gastroenterology
  - Crohn's Disease
  - Ulcerative Colitis
  - Search for:
- Hematology
  - BACK
  - Hematology
  - Chronic Immune Thrombocytopenia
  - Paroxysmal Nocturnal Hemoglobinuria
  - Sickle Cell Disease
  - Search for:
- Hepatology
  - BACK
  - Hepatology
  - Liver Fibrosis
  - Search for:
- Infectious Diseases
  - BACK
  - Infectious Diseases
  - Adolescent Vaccinations
  - COVID-19 Prevention
  - Influenza
  - Search for:
- Nephrology
  - BACK
  - Nephrology
  - IgAN
  - IgAN & C3G
  - Renal Transplant Maintenance
  - Search for:
- Neurology
- Oncology
- Ophthalmology
  - BACK
  - Ophthalmology
  - Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema
  - Wet AMD
  - Search for:
- Osteoporosis
  - BACK
  - Osteoporosis
  - Osteoporosis
  - Search for:
- Psychiatry
  - BACK
  - Psychiatry
  - Major Depressive Disorder
  - Schizophrenia
  - Tardive Dyskinesia
  - Search for:
- Pulmonology
  - BACK
  - Pulmonology
  - Asthma
  - COPD
  - Interstitial Lung Disease
  - Search for:
- Rheumatology
  - BACK
  - Rheumatology
  - Psoriatic Arthritis
  - Rheumatoid Arthritis
  - Systemic Lupus Erythematosus
  - Search for:
- Urology
  - BACK
  - Urology
  - Uncomplicated Urinary Tract Infections
  - Search for:
- Search for:
Conference Reporter
Expert Directory
About Expert Perspectives
Login/Register
Search for:

clinical topic updates

Bruton Tyrosine Kinase Inhibitor Selectivity and Perspectives on Investigational Combinations

Bruton Tyrosine Kinase Inhibitor Selectivity and Perspectives on Investigational Combinations

clinical topic updates
By Jeff Sharman, MD

Novel Small-Molecule Inhibitor–Based Combinations in Development for Chronic Lymphocytic Leukemia

Novel Small-Molecule Inhibitor–Based Combinations in Development for Chronic Lymphocytic Leukemia

clinical topic updates
By Jeff Sharman, MD

Halting the Progression of Liver Disease in Patients With Metabolic Syndrome

Halting the Progression of Liver Disease in Patients With Metabolic Syndrome

clinical topic updates
By Arun J. Sanyal, MD

Imaging- and Blood-Based Markers of Hepatic Fibrosis and Cirrhosis

Imaging- and Blood-Based Markers of Hepatic Fibrosis and Cirrhosis

clinical topic updates
By Raymond T. Chung, MD

Nonalcoholic Steatohepatitis: Monotherapies and Combination Therapies in Development

Nonalcoholic Steatohepatitis: Monotherapies and Combination Therapies in Development

clinical topic updates
By Raymond T. Chung, MD

Load More

2026 Expert Perspectives®

Privacy Policy Terms of Service About Expert Perspectives

Your California Privacy Rights Do Not Sell My Personal Information

Login Expert Perspectives

Forgot Password?

or Create an Account

Create an Account

Forgot Password?